Table 1.
Selected Maternal Characteristics of Neural Tube Defect Cases and Controls in the National Birth Defects Prevention Study, 1997–2005
Characteristic | Cases (n = 1,223) |
Controls (n = 6,807) |
||
No. | % | No. | % | |
Race/ethnicity* | ||||
Non-Hispanic white | 621 | 50.8 | 4,026 | 59.1 |
Non-Hispanic black | 114 | 9.3 | 771 | 11.3 |
Hispanic | 395 | 32.3 | 1,502 | 22.1 |
Asian/Pacific Islander | 25 | 2.0 | 200 | 2.9 |
Other | 64 | 5.2 | 279 | 4.1 |
Missing | 4 | 0.3 | 29 | 0.4 |
Educational level, years* | ||||
<9 | 98 | 8.0 | 330 | 4.8 |
9–11 | 159 | 13.0 | 800 | 11.8 |
12 | 347 | 28.4 | 1,652 | 24.3 |
13–15 | 338 | 27.6 | 1,806 | 26.5 |
>15 | 265 | 21.7 | 2,110 | 31.0 |
Missing | 16 | 1.3 | 109 | 1.6 |
Age at delivery, years* | ||||
<18 | 49 | 4.0 | 255 | 3.7 |
18–19 | 99 | 8.1 | 478 | 7.0 |
20–24 | 270 | 22.1 | 1,552 | 22.8 |
25–29 | 390 | 31.9 | 1,807 | 26.5 |
30–34 | 257 | 21.0 | 1,759 | 25.8 |
35–39 | 115 | 9.4 | 816 | 12.0 |
40–44 | 40 | 3.3 | 128 | 1.9 |
>44 | 3 | 0.2 | 12 | 0.2 |
Study center location* | ||||
Arkansas | 153 | 12.5 | 848 | 12.5 |
California | 240 | 19.6 | 858 | 12.6 |
Georgia | 148 | 12.1 | 735 | 10.8 |
Iowa | 146 | 11.9 | 759 | 11.2 |
Massachusetts | 74 | 6.1 | 859 | 12.6 |
North Carolina | 70 | 5.7 | 412 | 6.1 |
New Jersey | 70 | 5.7 | 574 | 8.4 |
New York | 72 | 5.9 | 601 | 8.8 |
Texas | 171 | 14.0 | 792 | 11.6 |
Utah | 79 | 6.5 | 369 | 5.4 |
Body mass index*,a | ||||
<18.5 | 49 | 4.0 | 361 | 5.3 |
18.5–24.9 | 576 | 47.1 | 3,640 | 53.5 |
25.0–29.9 | 254 | 20.8 | 1,463 | 21.5 |
>29.9 | 265 | 21.7 | 1,055 | 15.5 |
Missing | 79 | 6.5 | 288 | 4.2 |
Folic acid supplement use | ||||
No | 574 | 46.9 | 3,121 | 45.9 |
Yesb | 605 | 49.5 | 3,521 | 51.7 |
Missing | 44 | 3.6 | 165 | 2.4 |
Dietary folate equivalents, μgc | ||||
<331.73 | 320 | 26.7 | 1,636 | 24.6 |
331.73–491.13 | 306 | 25.6 | 1,682 | 25.3 |
491.14–722.40 | 278 | 23.2 | 1,688 | 25.4 |
>722.40 | 293 | 24.5 | 1,639 | 24.7 |
* P < 0.05 (cases vs. controls; subjects with complete data only).
Weight (kg)/height (m)2.
Refers to any use in the period 1 month before conception through 1 month after conception.
Quartiles are based on control women’s distributions in dietary folate equivalents, and data are restricted to women with daily energy intakes of 500–5,000 kcal. Dietary folate equivalents were calculated as food folate intake + (1.7 × synthetic folic acid intake).